Advanced Characterization Services for Biologicals and other Therapeutics
Immuneed AB offers, as a contract research organization, specialized services for immunotoxicology and immunophenotyping. Specifically detection of immune adverse events, immune cell activation, cellular biodistribution and efficacy measurements of your particular drug candidate. All based on a unique human whole-blood assay.
Our vision is to become World leading in immunological evaluation of biopharmaceuticals in human whole blood, with a specific focus on monoclonal antibodies (mAbs). Linking preclinical data to clinical reality.
Therapeutic Vaccine Development
Immuneed AB also develops a peptide-based conjugate vaccine building on a unique, patent pending idea that will enhance both peptide uptake and cellular immune activation.